ARCHIVES

EntreMed Begins Phase I/II Trial For Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Wilex, Fox Chase, Begin Trial Of WX-UK1 Targeting Invasion

May 28, 2004

Pacific Yew Act Would Result In Duplications, Delays In Taxol Production, Witnesses Say

March 13, 1992

Reader Finds Letter insulting to Ethic Group

February 16, 1996

Obituary: Connie Curran, 67, C-Change Executive Director

November 21, 2014

FDA: If Carboplatin Dose Is Based On Actual GFR Measurements, Package Insert Dosing Instructions Accurate

October 8, 2010

Trials show No Advantage for ABMT In Breast Cancer; Should Insurers Pay?

April 16, 1999